Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Calabrò

Showing results (1-10 of 46) with videos related to

Pageof 5
Sort By:
AIMS Neuroscience|January 25, 2021
The biological pathways of Alzheimer disease: a reviewMarco Calabrò, Carmela Rinaldi, Giuseppe Santoro, et al.
International Journal of Molecular Sciences|January 27, 2024
Network Analysis Performed on Transcriptomes of Parkinson's Disease Patients Reveals Dysfunction in Protein TranslationSimone D'Angiolini, Maria Lui, Emanuela Mazzon, et al.
International Journal of Molecular Sciences|March 28, 2024
In Silico Analysis Highlights Potential Predictive Indicators Associated with Secondary Progressive Multiple SclerosisMarco Calabrò, Maria Lui, Emanuela Mazzon, et al.
Journal of Affective Disorders|April 10, 2015
Enrichment pathway analysis. The inflammatory genetic background in Bipolar DisorderAntonio Drago, Concetta Crisafulli, Marco Calabrò, et al.
Pharmacogenomics|March 30, 2016
Possible biomarkers modulating haloperidol efficacy and/or tolerabilityStefano Porcelli, Concetta Crisafulli, Marco Calabrò, et al.
Journal of Affective Disorders|November 10, 2015
The microtubule-associated molecular pathways may be genetically disrupted in patients with Bipolar Disorder. Insights from the molecular cascadesAntonio Drago, Concetta Crisafulli, Antonina Sidoti, et al.
Expert Opinion on Drug Metabolism & Toxicology|June 17, 2016
Progress and prospects in pharmacogenetics of antidepressant drugsChiara Fabbri, Concetta Crisafulli, Marco Calabrò, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 3, 2015
A molecular pathway analysis informs the genetic background at risk for schizophreniaConcetta Crisafulli, Antonio Drago, Marco Calabrò, et al.
Gene|September 25, 2012
Identification of a novel CCM2 gene mutation in an Italian family with multiple cerebral cavernous malformations and epilepsy: a causative mutation?Rosalia D'Angelo, Concetta Scimone, Marco Calabrò, et al.
Cancer Drug Resistance (Alhambra, Calif.)|May 18, 2022
Pharmacogenetic and pharmacogenomic discovery strategiesConcetta Crisafulli, Petronilla Daniela Romeo, Marco Calabrò, et al.
Pageof 5

Showing results (1-10 of 46) with videos related to

Sort By:
Pageof 5
AIMS Neuroscience|January 25, 2021
The biological pathways of Alzheimer disease: a reviewMarco Calabrò, Carmela Rinaldi, Giuseppe Santoro, et al.
International Journal of Molecular Sciences|January 27, 2024
Network Analysis Performed on Transcriptomes of Parkinson's Disease Patients Reveals Dysfunction in Protein TranslationSimone D'Angiolini, Maria Lui, Emanuela Mazzon, et al.
International Journal of Molecular Sciences|March 28, 2024
In Silico Analysis Highlights Potential Predictive Indicators Associated with Secondary Progressive Multiple SclerosisMarco Calabrò, Maria Lui, Emanuela Mazzon, et al.
Journal of Affective Disorders|April 10, 2015
Enrichment pathway analysis. The inflammatory genetic background in Bipolar DisorderAntonio Drago, Concetta Crisafulli, Marco Calabrò, et al.
Pharmacogenomics|March 30, 2016
Possible biomarkers modulating haloperidol efficacy and/or tolerabilityStefano Porcelli, Concetta Crisafulli, Marco Calabrò, et al.
Journal of Affective Disorders|November 10, 2015
The microtubule-associated molecular pathways may be genetically disrupted in patients with Bipolar Disorder. Insights from the molecular cascadesAntonio Drago, Concetta Crisafulli, Antonina Sidoti, et al.
Expert Opinion on Drug Metabolism & Toxicology|June 17, 2016
Progress and prospects in pharmacogenetics of antidepressant drugsChiara Fabbri, Concetta Crisafulli, Marco Calabrò, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 3, 2015
A molecular pathway analysis informs the genetic background at risk for schizophreniaConcetta Crisafulli, Antonio Drago, Marco Calabrò, et al.
Gene|September 25, 2012
Identification of a novel CCM2 gene mutation in an Italian family with multiple cerebral cavernous malformations and epilepsy: a causative mutation?Rosalia D'Angelo, Concetta Scimone, Marco Calabrò, et al.
Cancer Drug Resistance (Alhambra, Calif.)|May 18, 2022
Pharmacogenetic and pharmacogenomic discovery strategiesConcetta Crisafulli, Petronilla Daniela Romeo, Marco Calabrò, et al.
Pageof 5